Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank41
5Y CAGR+3.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+3.2%/yr
Long-term compound
Percentile
P41
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.00% |
| Q3 2025 | 36.99% |
| Q2 2025 | 134.27% |
| Q1 2025 | -54.88% |
| Q4 2024 | 6.46% |
| Q3 2024 | 67.91% |
| Q2 2024 | 34.84% |
| Q1 2024 | -59.33% |
| Q4 2023 | 21.33% |
| Q3 2023 | 71.20% |
| Q2 2023 | -13.40% |
| Q1 2023 | 59.53% |
| Q4 2022 | -51.60% |
| Q3 2022 | 63.61% |
| Q2 2022 | 16.95% |
| Q1 2022 | -23.25% |
| Q4 2021 | 23.74% |
| Q3 2021 | 69.74% |
| Q2 2021 | 42.66% |
| Q1 2021 | 24.67% |
| Q4 2020 | 13.68% |
| Q3 2020 | 82.98% |
| Q2 2020 | 118.09% |
| Q1 2020 | -11.15% |
| Q4 2019 | -2.30% |
| Q3 2019 | -34.56% |
| Q2 2019 | 71.21% |
| Q1 2019 | 0.00% |